Escherichia coli ST131: a model for high-risk transmission dynamics of antimicrobial resistance.
European Projects
To find more information, please, get in touch with the International Management team at oficina.idi(ELIMINAR)@irycis.org
ST131TS
JPI
European upconversion network.
COST
The European upconversion network - from the design of photon-upconverting nanomaterials to biomedical applications (CM1403).
Nano2Clinic
COST
Cancer Nanomedicine – from the bench to the bedside (CA17140)
REPLAY (MSCA-IF)
MSCA / ERC
Analysing the role of history, chance and selection on the evolution of plasmid-mediated antibiotic resistance (895671).
RETENTION
H2020
heaRt failurE paTient managEment and iNTerventIOns usiNg continuous patient monitoring outside hospitals and real world data (965343)
RESILIENCE
H2020
Remote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines (945118).
VISION
H2020
Strategies to strengthen scientific excellence and innoVation capacIty for early diagnoSIs of gastrOintestinal caNcers (857381)
MICROCARE
FP7
A multicenter, randomized, placebo-controlled, parallel-arm clinical trial to evaluate the efficacy of DAV132 in preventing Clostridioides difficile infection in patients with newly diagnosed Acute Myeloid Leukemia or high-risk Myelodysplastic Syndrome treated with intensive chemotherapy.
3TR
IMI / IHI
Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory and Allergic Conditions
Conect4Children
IMI / IHI
The conect4children (collaborative network for European clinical trials for children (c4c)
EURECA
FP7
European prospective cohort study on Enterobacteriaceae showing resistance to carbapenems